tiprankstipranks
Trending News
More News >
Clearside Biomedical (CLSD)
OTHER OTC:CLSD
US Market

Clearside Biomedical (CLSD) Income Statement

Compare
1,073 Followers

Clearside Biomedical Income Statement

Last quarter (Q3 2025), Clearside Biomedical's total revenue was $201.00K, a decrease of -80.64% from the same quarter last year. In Q3, Clearside Biomedical's net income was $-5.97M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.66M$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit
$ 1.51M$ 7.87M$ 1.12M$ 29.57M$ 7.89M
Operating Expenses
$ 30.40M$ 32.72M$ 31.40M$ 30.20M$ 25.83M
Depreciation and Amortization
$ 226.00K$ 67.00K$ 145.00K$ 178.00K$ 180.00K
EBITDA
$ -24.35M$ -23.06M$ -29.46M$ 554.00K$ -17.70M
Operating Income
$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
Other Income/Expenses
$ -5.47M$ -7.64M$ -2.67M$ 1.00M$ -275.00K
Pretax Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Net Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Per Share Metrics
Basic EPS
$ -7.05$ -7.95$ -8.25$ 0.10$ -5.85
Diluted EPS
$ -7.05$ -7.95$ -8.25$ 0.09$ -5.85
Weighted Average Shares Outstanding
4.92M 4.12M 4.01M 3.90M 3.10M
Weighted Average Shares Outstanding (Diluted)
4.92M 4.12M 4.01M 3.99M 3.10M
Currency in USD

Clearside Biomedical Earnings and Revenue History